Henry K Su1, Bruce M Wenig2, Grace C Haser1, Meghan E Rowe1, Sylvia L Asa3, Zubair Baloch4, Eugenie Du5, William C Faquin6, Giovanni Fellegara7, Thomas Giordano8, Ronald Ghossein9, Virginia A LiVolsi4, Ricardo Lloyd10, Ozgur Mete3, Umut Ozbek11, Juan Rosai7, Saul Suster12, Lester D Thompson13, Andrew T Turk14, Mark L Urken15. 1. 1 Department of Otolaryngology-Head and Neck Surgery, Thyroid, Head and Neck Cancer (THANC) Foundation , New York, New York. 2. 2 Department of Pathology, Mount Sinai Beth Israel, New York, New York. 3. 3 Department of Pathology, Laboratory Medicine Program, Toronto General Hospital , Toronto, Canada . 4. 4 Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania , Philadelphia, Pennsylvania. 5. 5 Department of Otorhinolaryngology-Head and Neck Surgery, Montefiore Medical Center, Albert Einstein College of Medicine , Bronx, New York. 6. 6 Department of Pathology, Massachusetts General Hospital , Boston, Massachusetts. 7. 7 Centro Consulenze Anatomia Patologica Oncologica, Centro Diagnostico Italiano , Milan, Italy . 8. 8 Department of Pathology, University of Michigan Medical School , Ann Arbor, Michigan. 9. 9 Department of Pathology, Memorial Sloan-Kettering Cancer Center , New York, New York. 10. 10 Department of Pathology and Laboratory Medicine, University of Wisconsin , Madison, Wisconsin. 11. 11 Population Health Science and Policy, Mount Sinai Hospital , New York, New York. 12. 12 Department of Pathology, Medical College of Wisconsin , Milwaukee, Wisconsin. 13. 13 Department of Pathology, Woodland Hills Medical Center , Woodland Hills, California. 14. 14 Department of Pathology, New York-Presbyterian/Columbia , New York, New York. 15. 15 Department of Otolaryngology-Head and Neck Surgery , Mount Sinai Beth Israel , New York, New York.
Abstract
BACKGROUND: Extrathyroidal extension (ETE) is a significant prognostic factor in papillary thyroid carcinoma (PTC). Minimal extrathyroidal extension (mETE) is characterized by involvement of the sternothyroid muscle or perithyroid soft tissue, and is generally identified by light microscope examination. Patients with mETE, identified pathologically, are automatically upstaged to pT3. However, the prognostic implications of mETE have been a source of controversy in the literature. Moreover, there is also controversy surrounding the identification of mETE on pathological specimens. The objective of this study was to determine the level of agreement among expert pathologists in the identification of mETE in PTC cases. METHODS: Eleven expert pathologists from the United States, Italy, and Canada were asked to perform a review of 69 scanned slides of representative permanent sections of PTC specimens. Each slide was evaluated for the presence of mETE. The pathologists were also asked to list the criteria they use to identify mETE. RESULTS: The overall strength of agreement for identifying mETE was slight (κ = 0.14). Inter-pathologist agreement was best for perithyroidal skeletal muscle involvement (κ = 0.46, moderate agreement) and worst for invasion around thick-walled vascular structures (κ = 0.02, slight agreement). In addition, there was disagreement over the constellation of histologic features that are diagnostic for mETE, which affected overall agreement for diagnosing mETE. CONCLUSIONS: Overall agreement for the identification of mETE is poor. Disagreement is a result of both variation in individual pathologists' interpretations of specimens and disagreement on the histologic criteria for mETE. Thus, the utility of mETE in staging and treatment of PTC is brought into question. The lack of concordance may explain the apparent lack of agreement regarding the prognostic significance of this pathologic feature.
BACKGROUND: Extrathyroidal extension (ETE) is a significant prognostic factor in papillary thyroid carcinoma (PTC). Minimal extrathyroidal extension (mETE) is characterized by involvement of the sternothyroid muscle or perithyroid soft tissue, and is generally identified by light microscope examination. Patients with mETE, identified pathologically, are automatically upstaged to pT3. However, the prognostic implications of mETE have been a source of controversy in the literature. Moreover, there is also controversy surrounding the identification of mETE on pathological specimens. The objective of this study was to determine the level of agreement among expert pathologists in the identification of mETE in PTC cases. METHODS: Eleven expert pathologists from the United States, Italy, and Canada were asked to perform a review of 69 scanned slides of representative permanent sections of PTC specimens. Each slide was evaluated for the presence of mETE. The pathologists were also asked to list the criteria they use to identify mETE. RESULTS: The overall strength of agreement for identifying mETE was slight (κ = 0.14). Inter-pathologist agreement was best for perithyroidal skeletal muscle involvement (κ = 0.46, moderate agreement) and worst for invasion around thick-walled vascular structures (κ = 0.02, slight agreement). In addition, there was disagreement over the constellation of histologic features that are diagnostic for mETE, which affected overall agreement for diagnosing mETE. CONCLUSIONS: Overall agreement for the identification of mETE is poor. Disagreement is a result of both variation in individual pathologists' interpretations of specimens and disagreement on the histologic criteria for mETE. Thus, the utility of mETE in staging and treatment of PTC is brought into question. The lack of concordance may explain the apparent lack of agreement regarding the prognostic significance of this pathologic feature.
Authors: S Ortiz; J M Rodríguez; T Soria; D Pérez-Flores; A Piñero; J Moreno; P Parrilla Journal: Otolaryngol Head Neck Surg Date: 2001-03 Impact factor: 3.497
Authors: Jason B Clain; Sophie Scherl; Laura Dos Reis; Andrew Turk; Bruce M Wenig; Saral Mehra; William E Karle; Mark L Urken Journal: Thyroid Date: 2014-05-05 Impact factor: 6.568
Authors: D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke Journal: Eur J Cancer Date: 1979-08 Impact factor: 9.162
Authors: Sharon L Cushing; Carsten E Palme; Nathalie Audet; Spiro Eski; Paul G Walfish; Jeremy L Freeman Journal: Laryngoscope Date: 2004-12 Impact factor: 3.325
Authors: Jin Young Kwak; Eun-Kyung Kim; Ji Hyun Youk; Min Jung Kim; Eun Ju Son; Seon Hyeong Choi; Ki Keun Oh Journal: Thyroid Date: 2008-06 Impact factor: 6.568
Authors: N Chereau; T O Oyekunle; A Zambeli-Ljepović; H S Kazaure; S A Roman; F Menegaux; J A Sosa Journal: Br J Surg Date: 2019-04-23 Impact factor: 6.939
Authors: Robert Seifert; Michael Andreas Schäfers; Barbara Heitplatz; Laura Kerschke; Burkhard Riemann; Benjamin Noto Journal: J Nucl Med Date: 2021-03-26 Impact factor: 11.082
Authors: Yangyang Hao; Quan-Yang Duh; Richard T Kloos; Joshua Babiarz; R Mack Harrell; S Thomas Traweek; Su Yeon Kim; Grazyna Fedorowicz; P Sean Walsh; Peter M Sadow; Jing Huang; Giulia C Kennedy Journal: BMC Syst Biol Date: 2019-04-05
Authors: Ronald Ghossein; Justine A Barletta; Martin Bullock; Sarah J Johnson; Kennichi Kakudo; Alfred K Lam; Mufaddal T Moonim; David N Poller; Giovanni Tallini; R Michael Tuttle; Bin Xu; Anthony J Gill Journal: Hum Pathol Date: 2020-09-10 Impact factor: 3.466